ABSTRACT Cutaneous iododerma is a rare adverse reaction to iodine‐containing compounds that may clinically and histopathologically mimic infection, vasculitis, malignancy, and other neutrophilic dermatoses. Although most commonly associated with iodinated contrast exposure, a variety of predisposing factors and potential associations have been reported,
Volha Lenskaya +4 more
wiley +1 more source
Summary Background Erythropoietic protoporphyria (EPP) is a rare genetic disorder characterized by severe phototoxic reactions that occur within minutes of light exposure. In clinical studies, afamelanotide has been shown to prolong pain‐free sun exposure, improve quality of life, and reduce the frequency and severity of phototoxic reactions ...
Magdalena Seidl‐Philipp +9 more
wiley +1 more source
Transcriptional-secretory uncoupling in RDEB skin creates a non-permissive microenvironment for sensory nerve regeneration. [PDF]
Diaz P, Flores-Muñoz C, Calvo M.
europepmc +1 more source
Cyclophosphamide is associated with long‐term treatment‐free remission in patients with pemphigus
Summary Background and objective Pemphigus treatment has seen significant advancements, yet long‐term remission remains a challenge. Comparative data on the long‐term effectiveness of available therapies are limited. We compared 10‐year relapse rates in pemphigus patients treated with azathioprine or cyclophosphamide plus high‐dose IV corticosteroids ...
Bettina Santler +5 more
wiley +1 more source
Influence of Helicobacter pylori eradication blister-pack handling on outpatient AWaRe access share: a Japanese community pharmacy-based sensitivity analysis. [PDF]
Kishino Y +3 more
europepmc +1 more source
Atypical Presentation of Congenital Sucking Blister of the Lip: A Diagnostic Challenge. [PDF]
Lemos A +4 more
europepmc +1 more source
Skin Dose and Toxicity in Patients With Epidermolysis Bullosa Undergoing Radiation Therapy. [PDF]
MacDuffie E +6 more
europepmc +1 more source
Effect and length of doxycycline administration in elderly patients with bullous pemphigoid
Summary Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease and primarily affects the elderly. Systemic corticosteroids and immunosuppressive drugs are the standard treatment, but side effects often restrict their use. Doxycycline has been proposed as an alternative, but there is limited long‐term, real‐world data on its
Alena Merkel‐Ropele +2 more
wiley +1 more source
Dupilumab enables glucocorticoid withdrawal in refractory multisite mucous membrane pemphigoid: a case report. [PDF]
Hu Y, Xu LL, Li KH, Yu CS, Wang SB.
europepmc +1 more source

